Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Irinotecan. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP1 known ✓ | P11387 | 5/20 | 0.66 |
| ▸ | GLA | P06280 | 2/20 | 0.75 |
| ▸ | GAA | P10253 | 2/20 | 0.75 |
| ▸ | SLC22A2 | O15244 | 2/20 | 0.75 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.75 |
| ▸ | SLC47A2 | Q86VL8 | 2/20 | 0.75 |
| ▸ | SLC47A1 | Q96FL8 | 2/20 | 0.75 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.75 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.75 |
| ▸ | MMP1 | P03956 | 1/20 | 0.75 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.75 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.75 |
| ▸ | ACHE | P22303 | 1/20 | 0.75 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.74 |
| ▸ | LMNA | P02545 | 3/20 | 0.74 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.74 |
| ▸ | HPGD | P15428 | 1/20 | 0.74 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.74 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Irinotecan SCHEMBL478241 | 0.95 | GLA (0.84) | GLAGAASLC22A2CYP3A4SLC47A2 | |
| Irinotecan SCHEMBL1408971 | 0.91 | GLA (0.78) | GLAGAASLC22A2CYP3A4SLC47A2 | |
| Irinotecan SCHEMBL28244782 | 0.91 | GLA (0.78) | GLAGAASLC22A2CYP3A4SLC47A2 | |
| Irinotecan SCHEMBL29367581 | 0.87 | GLA (1.00) | GLAGAASLC22A2CYP3A4SLC47A2 | |
| Irinotecan SCHEMBL13420262 | 0.87 | GLA (1.00) | GLAGAASLC22A2CYP3A4SLC47A2 | |
| Irinotecan SCHEMBL12313065 | 0.87 | GLA (1.00) | GLAGAASLC22A2CYP3A4SLC47A2 | |
| Irinotecan SCHEMBL29356918 | 0.87 | GLA (1.00) | GLAGAASLC22A2CYP3A4SLC47A2 | |
| Irinotecan SCHEMBL4034 | 0.87 | GLA (1.00) | GLAGAASLC22A2CYP3A4SLC47A2 | |
| Irinotecan SCHEMBL19534323 | 0.87 | GLA (1.00) | GLAGAASLC22A2CYP3A4SLC47A2 | |
| Irinotecan SCHEMBL131381 | 0.87 | GLA (1.00) | GLAGAASLC22A2CYP3A4SLC47A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1556073-A2 | METHOD AND COMPOSITION FOR PREVENTING AND TREATING SOLID TUMORS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2005-07-27 | — | — | EP | disclosed |
| WO-2004037235-A2 | METHOD AND COMPOSITION FOR PREVENTING AND TREATING SOLID TUMORS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2004-05-06 | — | — | WO | disclosed |